Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

Updated September 30th, 2019

Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

A specific PARP inhibitor called Zejula more than doubled the amount of time that many women with ovarian cancer lived without their cancer getting worse.

NOW
PLAYING
Mom Discovers Inoperable Cancer Six Months After Beating Disease
NOW
PLAYING
Pelé Hospitalized For Chemo Treatment In Colon Cancer Battle
NOW
PLAYING
Cancer Patient's Chemo Surgery Cancelled Three Times Due To COVID
NOW
PLAYING
Teacher Battling Stage IV Ovarian Cancer After Only Weeks of Symptoms
NOW
PLAYING
Rex Tillerson Thought Kidney Cancer Symptoms Were White House Stress
NOW
PLAYING
Mom Battles Breast Cancer Three Times Despite Double Mastectomy

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.